Blog Archives

Big pharma mobilising patients in battle over drugs trials data


download (3)

The pharmaceutical industry has “mobilised” an army of patient groups to lobby against plans to force companies to publish secret documents on drugs trials.

Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs.

Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects.

While some companies have agreed to share data more freely, the industry has broadly resisted the moves. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.

The strategy was drawn up by two large trade groups, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), and outlined in a memo to senior industry figures this month, according to an email seen by the Guardian.

The memo, from Richard Bergström, director general of EFPIA, went to directors and legal counsel at Roche, Merck, Pfizer, GSK, AstraZeneca, Eli Lilly, Novartis and many smaller companies. It was leaked by a drugs company employee.

The email describes a four-pronged campaign that starts with “mobilising patient groups to express concern about the risk to public health by non-scientific re-use of data”. Translated, that means patient groups go into bat for the industry by raising fears that if full results from drug trials are published, the information might be misinterpreted and cause a health scare.

The lobbying is targeted at Europe where the European Medicines Agency (EMA) wants to publish all of the clinical study reports that companies have filed, and where negotiations around the clinical trials directive could force drug companies to publish all clinical trial results in a public database.

“Some who oppose full disclosure of data fear that publishing the information could reveal trade secrets, put patient privacy at risk, and be distorted by scientists’ own conflicts of interest. While many of the concerns are valid, critics say they can be addressed, and that openness is far more important for patient safety.”

Tim Reed, of Health Action International, a group that has previously exposed the pharmaceutical industry’s financial links with patient groups, said: “It’s incredibly ironic that this is a transparency initiative and we’ve now got clear indications that the pharmaceutical industry is ready to use patient organisations to fight their corner.

“It underlines the fact that patient groups who are in the pay of the pharmaceutical industry will go into battle for them. There’s a hidden agenda here. The patient groups will say they think it’s a great idea to keep clinical trials data secret. Why would they do that? They would do that because they are fronts for the pharmaceutical industry.

“Patient groups get traction because they are assumed to represent the voice of the suffering. But industry uses them to say we’re not going to get innovative medicines if the industry is deterred from investing by having to be transparent about their clinical trials,” he added.

A recent review of medical research estimated that only half of all clinical trials were published in full, and that positive results were twice as likely to be published than negative ones.

A source in the European parliament, who is close to the negotiations over the clinical trials directive, said he had experienced intense lobbying from patient groups. “We’ve witnessed this sort of activity in recent months, and it’s a concern if the pharmaceutical industry is behind some of it. They are trying to weaken some of the transparency proposals and that’s clear from the amount of lobbying we’ve had,” he said.

The patient groups focus on the concern that if companies release all of their clinical trials data, the information might be misconstrued, or intentionally cherry-picked, and spark damaging health scares around certain drugs or vaccines.

“These aren’t completely unfounded concerns, but the risk already exists, and those things already happen. The answer is to have a responsible scientific community that can counteract the allegations and claims,” the source said.

Two other strands of the campaign include discussions with scientific associations about the risks of data sharing, and work with other businesses that are concerned about the release of trade secrets and confidential data. The final strand calls, in the long term, for a network of academics across Europe that can be called on to correct false interpretations of the data. “That is deemed to be happening in any case,” the memo concedes.

In response to queries from the Guardian, GSK said: “This is not something we are doing. One of the reasons we’re involved in this is we want more companies to move towards greater transparency. I don’t think it’s for us to be mobilising patient groups to campaign on a negative level.”

A Roche spokesperson said the company consulted patient groups to understand their concerns about clinical trials, but “to our knowledge Roche has not been involved in any EFPIA’s potential activity in mobilising patient groups to express concern about the risk to public health by non-scientific re-use of data”.

A Lilly spokesman said: “Lilly is committed to working with Europe-based patient advocacy organisations for the benefit of patients in a way that is true to the EFPIA code of practice and Lilly’s integrity in business policy.”

Individuals who received the memo at several other companies, including AstraZeneca and Novartis, did not respond.

Tracey Brown, director of the campaign group, Sense about Science, and co-founder of AllTrials, a campaign to get all clinical trials registered and all results reported, said: “We now have the prospect of really significant developments to end the secrecy and make clinical trial reporting a practical reality and, finally, some sound commitments from parts of industry.

“In this context, the industry associations’ strategy to get others to raise further spurious problems is backward. It should embarrass anyone associated with it. I would say to the individual companies that they should publicly distance themselves from any association with EFPIA and PhRMA’s strategy now,” she said.

The EFPIA told the Guardian it had been working with PhRMA on a “commitment to enhance sharing of clinical data” to researchers and the public, and intended to make an announcement this week.

“Knowing that some people want all data to be made available to everyone, EFPIA is engaging with stakeholders to share concerns with harmful ‘re-use’ of data. We will engage not only with patient groups, but also with the scientific community,” it said.

Matt Bennett, senior vice-president of PhRMA, said in a statement: “EMA’s proposed policies on clinical trial information raise numerous concerns for patients. We believe it is important to engage with all stakeholders in the clinical trial ecosystem, including the patients who volunteer to participate in clinical trials, about the issue.

“If enacted, the proposals could risk patient privacy, lead to fewer clinical trials, and result in fewer new medicines to meet patient needs and improve health.”

via Big pharma mobilising patients in battle over drugs trials data | Business | The Guardian.

GlaxoSmithKline Alleged to Pay Bribes in China


GlaxoSmithKline (GSK) has been accused of bribing doctors in China in order to boost sales. Chinese government officials say they have uncovered evidence of a bribery scheme involving 700 travel agencies who were used to funnel as much as three billion yuan ($480 million) in payments.

“We found that bribery is a core part of the activities of the company,” Gao Feng, the head of China’s fraud unit, said. “There is always a big boss in criminal organisations and in this case GSK is the big boss.”

Allegations about bribes at GSK first surfaced in January of this year in a series of tips made by an anonymous individual to company officials. The whistleblower alleged that the UK company made payments of $249 to $490 to promote Botox, a toxin used for medical purposes as well as for cosmetic purposes to get rid of wrinkles.

Soon after, the Wall Street Journal says it reviewed documents from as late as April 2013 for an internal GSK project called “Vasily” to pay 48 doctors who promoted Botox with “either a percentage of the cash value of the prescription or educational credits” depending on how many sales they made. GSK officials were encouraged to discuss the scheme on personal email accounts.

“I recommend that everyone else use a private email account because it will be better that way,” Ruiting “Candy” Chen, Glaxo central nervous system marketing manager said in an email translated by the Journal. “Remember you must send to personal email accounts, you accidentally sent to [another sales team member’s] public mail, careful next time!” wrote Any Zheng, Botox regional sales manager.

Chinese media reported on Monday that GSK allegedly made payments to the travel agencies which then transferred the money to doctors via credit cards when they made prescriptions. The travel agencies booked the payments for travel expenses to fake meetings.

GSK says it has suspended all work with the travel agencies. It also says Vasily was never implemented and has denied the charges.

“We take all allegations of bribery and corruption seriously,” a spokesman said in a press statement. “We continuously monitor our businesses to ensure they meet our strict compliance procedures. We have done this in China and found no evidence of bribery or corruption of doctors or government officials. However, if evidence of such activity is provided we will act swiftly on it.”

Chinese officials say that Mark Reilly, the head of GSK operations in China, fled the country on June 27 and has not returned. Several other executives have been arrested.

“The anonymous claims highlight the challenges multinational pharmaceutical companies face in China, one of their most significant and fastest-growing markets, because its health-care system is controlled and owned by the state and it has a tradition of government patronage and gift-giving,” write Christopher Matthews and Jessica Hodgson of the Wall Street Journal.

In reality, the comment by the Journal reporters reflects a bias on their part. GSK has been found guilty of routinely offering U.S. doctors lavish payments for promoting company products, despite the absence of a state health care system.

In July 2012 GSK agreed to pay out $3 billion to settle charges on pushing bupropion and paroxetine (as well as their failure to report safety data about the drug Avandia to the U.S. Food and Drug Administration) — the largest such fine ever paid by a pharmaceutical company.

The U.S. Department of Justice noted that the company gave out “cash payments disguised as consulting fees, expensive meals, weekend boondoggles and lavish entertainment.” For example, doctors who promoted Wellbutrin were taken on “training sessions” to Jamaica. “Dr. Drew,” a TV doctor, was paid $275,000 in two months in 1999 alone to “deliver messages about [Wellbutrin SR] in settings where it did not appear that Dr. Pinsky was speaking for GSK.”

Nor was it the only Western pharmaceutical company accused of paying bribes to doctors to promote its products. In August 2012, in a criminal complaint issued by the U.S. Securities and Exchange Commission, investigators laid out detailed charges against Pfizer for paying bribes in eight countries: Bulgaria, China, Croatia, Czech Republic, Italy, Kazakhstan, Russia, and Serbia.

For example, Pfizer Italy employees provided free cell phones, photocopiers, printers and televisions to doctors, arranged for vacations (such as “weekend in Gallipoli,” “weekend with companion” and “weekend in Rome”) and even made direct cash payments (under the guise of lecture fees and honoraria) in return for promises by doctors to recommend or prescribe Pfizer’s products.

http://www.corpwatch.org/index.php

via OpEdNews – Article: CorpWatch : GlaxoSmithKline Alleged to Pay Bribes in China.

The Office of Fair Trading accuses GSK of ‘pay-for-delay’ deals to protect drug


Big Pharma up to dodgy tricks again

The pharmaceutical companies are no strangers to skulduggery and market manipulation. They are behind the biggest marketing scam on the planet; namely, creating a multi-billion dollar global market for a completely useless product on the back of junk science and manufactured fanaticism. The parallels with the AGW scam are  inescapable

Considering Seroxat’s shady history I’d have thought they would be happy to be shot of it…and then I remembered how much profit it makes them!

The suppression of unfavorable research findings on Paxil (Seroxat) by GSK — and the legal discovery process that uncovered it — is the subject of Alison Bass’s 2008 book Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial.

The Office of Fair Trading has said it had found evidence that the FTSE100 pharmaceutical giant made “substantial payments” to Alpharma, Generics UK and Norton Healthcare which it claims were used to stop them releasing version of its paroxetine anti-depressant drug.

In a “statement of objections” released on Friday, the anti-trust watchdog alleged that the agreements “infringed competition law” which in turn hits National Health Service costs.

Ann Pope, Senior Director of Services, Infrastructure and Public Markets at the OFT, said: “The introduction of generic medicines can lead to strong competition on price, which can drive savings for the NHS, to the benefit of patients and, ultimately, taxpayers. It is therefore particularly important that the OFT fully investigates concerns that independent generic entry may have been delayed in this case.”

Ms Pope said the allegation were not confirmed but are being investigated.

The OFT maintains that the three generic companies were each attempting to supply a generic paroxetine product in competition to GSK’s branded version of the drug called Seroxat.

It is alleged that GSK approached the firms and accused them of infringing on its patents on the drug which was at the time one of its best sellers. The disputes were resolved by a series of agreements.

“The OFT’s provisional view is that these agreements included substantial payments from GSK to the generic companies in return for their commitment to delay their plans to supply paroxetine independently,” the OFT said.

“The OFT considers that if companies act to delay the potential emergence of generic competition the NHS may be denied significant cost savings.”

In an emailed comment a spokesman said GSK had just received the OFT objections and needed “time to carefully review it”.

However, he said the allegations related to events that occurred between 2001 and 2004 that the European Commission had already investigated and “concluded its enquiry with no further action”.

The spokesman said: “GSK supports fair competition and we strongly believe that we acted within the law, as the holder of valid patents for paroxetine, in entering the agreements under investigation. These arrangements actually resulted in generic versions of paroxetine entering the market before GSK’s patents had expired.”

He added: “We have cooperated fully with the Office of Fair Trading in this investigation, which covers activities that happened between 2001 and 2004. The paroxetine supply agreements under investigation were terminated in 2004.”

via OFT accuses GSK of ‘pay-for-delay’ deals to protect drug – Telegraph.

via OFT accuses GSK of ‘pay-for-delay’ deals to protect drug – Telegraph.

Glaxo Chief: Our Drugs Do Not Work on Most Patients


A senior executive with Britain’s biggest drugs company has admitted that most prescription medicines do not work on most people who take them.

Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline (GSK), said fewer than half of the patients prescribed some of the most expensive drugs actually derived any benefit from them.

It is an open secret within the drugs industry that most of its products are ineffective in most patients but this is the first time that such a senior drugs boss has gone public. His comments come days after it emerged that the NHS drugs bill has soared by nearly 50 per cent in three years, rising by £2.3bn a year to an annual cost to the taxpayer of £7.2bn. GSK announced last week that it had 20 or more new drugs under development that could each earn the company up to $1bn (£600m) a year.

Dr Roses, an academic geneticist from Duke University in North Carolina, spoke at a recent scientific meeting in London where he cited figures on how well different classes of drugs work in real patients.

Drugs for Alzheimer’s disease work in fewer than one in three patients, whereas those for cancer are only effective in a quarter of patients. Drugs for migraines, for osteoporosis, and arthritis work in about half the patients, Dr Roses said. Most drugs work in fewer than one in two patients mainly because the recipients carry genes that interfere in some way with the medicine, he said.

“The vast majority of drugs – more than 90 per cent – only work in 30 or 50 per cent of the people,” Dr Roses said. “I wouldn’t say that most drugs don’t work. I would say that most drugs work in 30 to 50 per cent of people. Drugs out there on the market work, but they don’t work in everybody.”

Some industry analysts said Dr Roses’s comments were reminiscent of the 1991 gaffe by Gerald Ratner, the jewellery boss, who famously said that his high street shops are successful because they sold “total crap”. But others believe Dr Roses deserves credit for being honest about a little-publicised fact known to the drugs industry for many years.

“Roses is a smart guy and what he is saying will surprise the public but not his colleagues,” said one industry scientist. “He is a pioneer of a new culture within the drugs business based on using genes to test for who can benefit from a particular drug.”

Dr Roses has a formidable reputation in the field of “pharmacogenomics” – the application of human genetics to drug development – and his comments can be seen as an attempt to make the industry realise that its future rests on being able to target drugs to a smaller number of patients with specific genes.

The idea is to identify “responders” – people who benefit from the drug – with a simple and cheap genetic test that can be used to eliminate those non-responders who might benefit from another drug.

This goes against a marketing culture within the industry that has relied on selling as many drugs as possible to the widest number of patients – a culture that has made GSK one of the most profitable pharmaceuticals companies, but which has also meant that most of its drugs are at best useless, and even possibly dangerous, for many patients.

Dr Roses said doctors treating patients routinely applied the trial-and-error approach which says that if one drug does not work there is always another one. “I think everybody has it in their experience that multiple drugs have been used for their headache or multiple drugs have been used for their backache or whatever.

“It’s in their experience, but they don’t quite understand why. The reason why is becausethey have different susceptibilities to the effect of that drug and that’s genetic,” he said.

via Old News on Pharma Drugs Inefficiency | Engineered Ignorance.

via Old News on Pharma Drugs Inefficiency | Engineered Ignorance.

Big Pharma: Enemies Of Humanity?


Everyone knows about the sick, depraved monsters of the Third Reich – Hitler, Himmler, Mengele and the rest. Well, there is an evil just as insidious on the planet today. It isn’t as widely known as it should be – that’s one of the reasons why it is so insidious. They are predators that are so wealthy and so devious that they are able to hide behind a veil of legality and respectability. Actually, the most treacherous aspect of this story is the fact that they are a significant part of the health industry. Yes, the HEALTH industry.

While hard-working people struggle to make ends meet and take care of their children to the best of their abilities, these traitorous criminals are amassing enormous sums of money to provide “necessary” drugs to ensure a healthy population. Or so we thought.

Now, for the multibillion dollar pharmaceutical corporations to make obscene amounts of money while actually providing life-saving drugs would be one thing. However, when an industry entrusted with people’s health actually creates a cartel and conspires to keep the masses sick to protect their profits while sucking billions of dollars out of the economy – well, that’s quite another.

Pharmaceutical corporations have morphed in recent years into something more like a criminal organization than an integral part of our healthcare system. Now, how have they been able to do this without creating a storm of maniacal rage from the public? The main reason why they – or corporations in any industry for that matter –  can get away with such ominously destructive behavior is that they are able to hide the fact that they rig the system by disseminating propaganda in a nation in which everything from elections to creative public relations is for sale.

First, they have legislation written for them by so called “industry experts” that are designed to bypass health and/or safety regulations while creating the illusion they are doing what’s best for the public (research the nefarious dealings of ALEC). Then, they purchase positions in government and put spies in place to quickly push this legislation (that they call regulation) through the normal bureaucratic process. This is possible because they have managed to increase their influence in Wall Street circles – partially due to duplicitous corporate in-breeding with the criminally insane Banking and Insurance Cartels. And, finally, because corporations have purchased virtually every media outlet in the nation they are able to indoctrinate the masses into believing their sociopathic behavior is acceptable and is aimed toward “progress”. This includes the group of corporations known collectively as Big Pharma.

For every dollar the drug companies spend on research, they spend 19 dollars on marketing. Interestingly, paid mouthpieces for the Big Pharma {like the Galen Institute, an industry-funded organization that promotes so-called “free market” policies} publically state that the drug companies have had to decrease funding for research and development due to regulation. Well, this regulation they speak of is something of a mystery to the rest of the planet. In fact, more than 80% of basic funding for new drugs and vaccines comes from public sources. Apparently, pharmaceuticals is another industry (like war) in which corporations benefit from taxpayer money while reaping a harvest of obscene profits.

A study on the pharmaceutical industry was done by Donald Light, a professor of social medicine and comparative health care at the University of Medicine & Dentistry of New Jersey, and Joel Lexchin, a professor of health policy and management at York University in Toronto. One of the facts they uncovered was that while the industry’s research and development costs have risen significantly between 1995 & 2010 (approximately $30 billion), profits have increased much more so in that same time period (over $200 billion). “Net profits after taxes consistently remain substantially higher than profits for all other fortune 500 companies”, according to the study.

Sometimes, nothing other than the concepts of justice and democracy are hurt from this greedy, manipulative behavior. Other times, however, the damage is much more deadly.

In 2010, Merck & Co. settled a lawsuit in which 3,468 people died of heart attacks and strokes associated with use of Vioxx, a painkiller they manufactured. Yes, three thousand four hundred sixty eight people. Dead. They were accused of not releasing safety data to the FDA, making innaccurate and misleading statements about the cardiovascular safety of the drug and illegally promoting “off label” uses of it. Meanwhile, they were more than happy to collect over $11 billion in sales of Vioxx from 1999 – 2004. This means that for six years a multi-billion dollar corporation spent untold amounts of money in litigation costs to avoid compensating the victims of their criminally insane greed. On top of this already sordid tale of unethical activity, another fact attests to the viciousness of this crime. Merck never admitted liability for the deaths attributed to their product. We can only imagine how many times corporations have gotten away with this type of crime without being caught.

Merck is not the only corporation in which management puts personal profit over the safety and well being of their customers. In 2012, GlaxoSmithKline pleaded guilty to extremely disturbing charges related to several of their medications. In the case of their antidepressant drug, Paxil, the company tried to promote use in children and was caught helping publish a medical journal article with misleading data from a clinical trial. One of the facts that was supressed is that there was significant evidence of suicidal thoughts in teenagers who were tested. Can’t have dead teenagers holding back profits. It might affect their value at the NYSE. With their drug, Wellbutrin, they jumped on the bandwagon of self-centered obsession with youth and physical appearance by promoting it for sexual dysfunction and weight loss. It was only designed for use as an anti-depressant. With yet another drug, Avandia, they failed to report data to the FDA about heart risks discovered during testing. Avandia is a medication for diabetes. How nice, deceive people and have them trade their diabetes for heart trouble.

Another aspect of this story of insatiable greed and lack of empathy is that overdoses of prescription sedatives and painkillers have killed more people than heroin and cocaine combined, yet are legal. Hospitalizations from poisonings attributed to these legal drugs increased 65% from 1999 to 2006. Over the same period of time, the increase of poisonings due to illegal drugs is half that rate. Some doctors consider prescription drug deaths the biggest man-made epidemic in the U.S. However, try telling law enforcement officials who listen to the propaganda put out by pharmaceutical lobbyists to arrest the pushers of prescription drugs. Jail is for the working class – not for wealthy people who live in mansions.

While Big Pharma has unscrupulously been filling their coffers with their ill-gotten gains, almost one-quarter of the U.S. population over the age of 50 has had to cut back on dosages or switch to generic brands due to price increases. Pharmaceutical corporations have had tremendous success in lobbying criminal elements inside our government to prevent Medicare and Medicaid from bargaining for affordable drug prices. In Canada, the provinces negotiate with drug companies for lower prices. This has kept prices in Canada significantly lower than in the U.S. – even when medications are imported from their southern neighbors. A recent survey among legitimate online pharmacies revealed prices in Canada ranging from 40% – 70% lower than their U.S. counterparts.

Oh, and one more thought about the lack of humanity on Wall Street: after their lawsuit was announced in 2010, Merck’s stock dropped 1% or about 33 cents per share. Is that all we value human life these days?

via Big Pharma: Enemies Of Humanity? | ashiftinconsciousness.

via Big Pharma: Enemies Of Humanity? | ashiftinconsciousness.

Drug giants fined $11bn for criminal wrongdoing


The global pharmaceutical industry has racked up fines of more than $11bn in the past three years for criminal wrongdoing, including withholding safety data and promoting drugs for use beyond their licensed conditions.

In all, 26 companies, including eight of the 10 top players in the global industry, have been found to be acting dishonestly. The scale of the wrongdoing, revealed for the first time, has undermined public and professional trust in the industry and is holding back clinical progress, according to two papers published in today’s New England Journal of Medicine. Leading lawyers have warned that the multibillion-dollar fines are not enough to change the industry’s behaviour.

The 26 firms are under “corporate integrity agreements”, which are imposed in the US when healthcare wrongdoing is detected, and place the companies on notice for good behaviour for up to five years.

The largest fine of $3bn, imposed on the UK-based company GlaxoSmith-Kline in July after it admitted three counts of criminal behaviour in the US courts, was the largest ever. But GSK is not alone – nine other companies have had fines imposed, ranging from $420m on Novartis to $2.3bn on Pfizer since 2009, totalling over $11bn.

Kevin Outterson, a lawyer at Boston University, says that despite the eye watering size of the fines they amount to a small proportion of the companies’ total revenues and may be regarded as a “cost of doing business”. The $3bn fine on GSK represents 10.8 per cent of its revenue while the $1.5bn fine imposed on Abbott Laboratories, for promoting a drug (Depakote) with inadequate evidence of its effectiveness, amounted to 12 per cent.

Mr Outterson said: “Companies might well view such fines as a quite small percentage of their global revenue. If so, little has been done to change the system. The government merely recoups a portion of the financial fruit of firms’ past misdeeds.”

He argues that penalties should be imposed on executives rather than the company as whole. He cites a Boston whistleblower attorney, Robert Thomas who observed that GSK had committed a $1bn crime and “no individual has been held responsible”.

Following GSK’s admission that it had withheld safety data about its best-selling diabetes drug Avandia, the company pledged to make more clinical trial information available. But the pledge has “disturbing exceptions”, according to Mr Outterson, and in any case is made under the corporate integrity agreement, which expires in five years.

Trust in the industry among doctors has fallen so low that they dismiss clinical trials funded by it, even when the trials have been conducted with scientific rigour, according to a second paper in the journal by researchers at Brigham and Women’s Hospital, Boston. This could have serious implications because most medical research is funded by the drug industry and “if physicians are reluctant to trust all such research, it could hinder the translation of … research into practice,” said Aaron Kesselheim, who led the study.

Andrew Witty, the chief executive of GSK, said at the time of the $3bn settlement last July that it had resolved “difficult, long-standing matters” for the company and that there had since been a “fundamental change in procedures” including the removal of staff engaged in misconduct and changes to incentive payments.

The Association of the British Pharmaceutical Industry said practices in the industry had improved and more changes to “build greater levels of trust” would be made. The UK Medicines and Healthcare Products Regulatory Agency said it monitored the conduct of companies and took “appropriate action” when it uncovered malpractice.

Alzheimer’s funding ‘must continue’

Governments, universities and charities should step in to ensure funding is maintained for research into Alzheimer’s disease, following a series of failed drug trials, experts said yesterday.

They were responding to a report in The Independent that the world’s leading drug companies are giving up on the search for a cure, scaling back their neuroscience departments and focusing on symptomatic, rather than disease-modifying, treatments.

A spokesman for the Alzheimer’s Society said: “This is not the time to back away from dementia research. Despite costing the economy more than cancer and heart disease, funding for research into dementia is only a fraction of these conditions. More funding is urgently needed if we are to defeat it.”

Jeremy Laurance

via Drug giants fined $11bn for criminal wrongdoing – Health News – Health & Families – The Independent.

via Drug giants fined $11bn for criminal wrongdoing – Health News – Health & Families – The Independent.

Big Pharma criminality no longer a conspiracy theory: Bribery, fraud, price fixing now a matter of public record


images (1)

 

Those of us who have long been describing the pharmaceutical industry as a “criminal racket” over the last few years have been wholly vindicated by recent news. Drug and vaccine manufacturer Merck was caught red-handed by two of its own scientists faking vaccine efficacy data by spiking blood samples with animal antibodies. GlaxoSmithKline has just been fined a whopping $3 billion for bribing doctors, lying to the FDA, hiding clinical trial data and fraudulent marketing. Pfizer, meanwhile has been sued by the nation’s pharmacy retailers for what is alleged as an “overarching anticompetitive scheme” to keep generic cholesterol drugs off the market and thereby boost its own profits.

The picture that’s emerging is one of a criminal drug industry that has turned to mafia tactics in the absence of any real science that would prove their products to be safe or effective. The emergence of this extraordinary evidence of bribery, scientific fraud, lying to regulators and monopolistic practices that harm consumers is also making all those doctors and “skeptics” who defended Big Pharma and vaccines eat their words.

To defend Big Pharma today is to defend a cabal of criminal corporations that have proven they will do anything — absolutely anything — to keep their profits rolling in. It makes no difference who they have to bribe, what studies they have to falsify, or who has to be threatened into silence. They will stop at nothing to expand their profit base, even if it means harming (or killing) countless innocents.

Let’s take a look at recent revelations:

GlaxoSmithKline pleads guilty to bribery, fraud and other crimes

It what is now the largest criminal fraud settlement ever to come out of the pharmaceutical industry, GlaxoSmithKline has pleaded guilty and agreed to pay $1 billion in criminal fines and $2 billion in civil fines following a nine-year federal investigation into its activities.

• Routinely bribed doctors with luxury vacations and paid speaking gigs

• Fabricated drug safety data and lied to the FDA

Defrauded Medicare and Medicaid out of billions

• Deceived regulators about the effectiveness of its drugs

• Relied on its deceptive practices to earn billions of dollars selling potentially dangerous drugs to unsuspecting consumers and medical patients

And this is just the part they got caught doing. GSK doesn’t even deny any of this. The company simply paid the $3 billion fine, apologized to its customers, and continued conducting business as usual.

By the way, in addition to bribing physicians, GSK has plenty of money to spread around bribing celebrities and others who pimps its products. The company reportedly paid $275,000 to the celebrity doctor known as “Dr. Drew,” who promoted Glaxo’s mind-altering antidepressant drug Wellbutrin

As the Wall Street Journal reports:

In June 1999, popular radio personality Dr. Drew Pinsky used the airwaves to extol the virtues of GlaxoSmithKline PLC’s antidepressant Wellbutrin, telling listeners he prescribes it and other medications to depressed patients because it “may enhance or at least not suppress sexual arousal” as much as other antidepressants do. But one thing listeners didn’t know was that, two months before the program aired, Dr. Pinsky — who gained fame as “Dr. Drew” during years co-hosting a popular radio sex-advice show “Loveline” — received the second of two payments from Glaxo totaling $275,000 for “services for Wellbutrin.”

Merck falsified vaccine data, spiked blood samples and more, say former employees

According to former Merck virologists Stephen Krahling and Joan Wlochowski, the company:

• “Falsified test data to fabricate a vaccine efficacy rate of 95 percent or higher.”

• Spiked the blood test with animal antibodies in order to artificially inflate the appearance of immune system antibodies.

• Pressured the two virologists to “participate in the fraud and subsequent cover-up.”

• Used the falsified trial results to swindle the U.S. government out of “hundreds of millions of dollars for a vaccine that does not provide adequate immunization.”

• Intimidated the scientists, threatening them with going to jail unless they stayed silent.

This is all documented in a 2010 False Claims Act which NaturalNews has acquired and posted here:

http://www.naturalnews.com/gallery/documents/Merck-False-Claims-Act.p…

Millions of children put at risk by Merck

In that document the two virologists say they, “witnessed firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the vaccine’s efficacy findings.”

They also claim that because of the faked vaccine results, “the United States has over the last decade paid Merck hundreds of millions of dollars for a vaccine that does not provide adequate immunization… The United States is by far the largest financial victim of Merck’s fraud.”

They go on to point out that children are the real victims, however:

“But the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection. …The failure in Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur.”

Merck’s mumps viral strain is 45 years old!

According to the complaint, Merck has been using the same mumps strain — weakened from generations of being “passaged” — for the last 45 years! The complaint reads:

“For more than thirty years, Merck has had an exclusive license from the FDA to manufacture and sell a mumps vaccine in the U.S. The FDA first approved the vaccine in 1967. It was developed by Dr. Maurice Hilleman, at Merck’s West Point research facility, from the mumps virus that infected his five year-old daughter Jeryl Lynn. Merck continues to use this ‘Jeryl Lynn’ strain of the virus for its vaccine today.”

A complete medical farce

This information appears to show Merck’s mumps vaccine to be a complete medical farce. Those who blindly backed Merck’s vaccines — the science bloggers, “skeptics,” doctors, CDC and even the FDA — have been shown to be utter fools who have now destroyed their reputations by siding with an industry now known to be dominated by scientific fraud and unbounded criminality.

That’s the really hilarious part in all this: After decades of doctors, scientists and government authorities blindly and brainlessly repeating the mantra of “95% effectiveness,” it all turns out to be total quackery hogwash. Utterly fabricated. Quackety-quack quack. And all those hundreds of millions of Americans who lined up to be injected with MMR vaccines were all repeatedly and utterly conned into potentially harming themselves while receiving no medical benefit.

Intelligent, informed NaturalNews readers, home school parents, and “awakened” people who said “No!” to vaccines are now emerging as the victors in all this. By refusing to be injected with Merck’s vaccines, they avoided being assaulted with a fraudulent cocktail of adjuvant chemicals and all-but-useless mumps strains over four decades old. They protected their time, money and health. Those who refuse to be physically violated by vaccines are, once again, turning out to be the smartest people in society. No wonder they also tend to be healthier than the clueless fools who line up to get vaccinated every year.

Merck fraudulently misrepresented the efficacy of its vaccine and contributed to the spread of infectious disease, says lawsuit

The faked vaccine efficacy numbers aren’t the only troubles Merck is now facing. Shortly after the above False Claims Act was made public, Chatom Primary Care filed suit against Merck.

It alleges that:

• [Merck engaged in] …a decade-long scheme to falsify and misrepresent the true efficacy of its vaccine.

• Merck fraudulently represented and continues to falsely represent in its labeling and elsewhere that its Mumps Vaccine has an efficacy rate of 95 percent of higher.

• Merck knows and has taken affirmative steps to conceal — by using improper testing techniques and falsifying test data — that its Mumps Vaccine is, and has been since at least 1999, far less than 95 percent effective.

• Merck designed a testing methodology that evaluated its vaccine against a less virulent strain of the mumps virus. After the results failed to yield Merck’s desired efficacy, Merck abandoned the methodology and concealed the study’s findings.

• Merck also engaged in “incorporating the use of animal antibodies to artificially inflate the results… destroying evidence of the falsified data and then lying to an FDA investigator… threatened a virologist in Merck’s vaccine division with jail if he reported the fraud to the FDA.”

• “Merck designed a testing methodology that evaluated its vaccine against a less virulent strain of the mumps virus. After the results failed to yield Merck’s desired efficacy, Merck abandoned the methodology and concealed the study’s findings. [Then] Merck designed even more scientifically flawed methodology, this time incorporating the use of animal antibodies to artificially inflate the results, but it too failed to achieve Merck’s fabricated efficacy rate. Confronted with two failed methodologies, Merck then falsified the test data to guarantee the results it desired. Having achieved the desired, albeit falsified, efficacy threshold, Merck submitted these fraudulent results to the FDA and European Medicines Agency.”

• “Merck took steps to cover up the tracks of its fraudulent testing by destroying evidence of the falsified data and then lying to an FDA investigator… Merck also attempted to buy the silence and cooperation of its staff by offering them financial incentives to follow the direction of Merck personnel overseeing the fraudulent testing process. Merck also threatened… Stephen Krahling, a virologist in Merck’s vaccine division from 1999 to 2001, with jail if he reported fraud to the FDA.”

• “Merck continued to conceal what it knew about the diminished efficacy of its Mumps Vaccine even after significant mumps outbreaks in 2006 and 2009.”

Obama administration has zero interest in actual justice

Another interesting note in all this is that under President Obama, the U.S. Dept. of Justice showed no interest whatsoever in investigating Merck over the False Claims Act filed by two of its former virologists. Despite the convincing evidence of fraud described in detail by insider whistleblowers, the Obama Department of Justice, led by gun-running Attorney General Eric Holder who is already facing serious questions over Operation Fast and Furious, simply chose to ignore the False Claims Act complaint.

When evidence of criminal fraud was brought before the U.S. Department of Justice, in other words, the DoJ looked the other way with a wink and a nod to the medical crimes taking place right under their noses. Who cares if tens of millions of children are being injected year after year with a fraudulent mumps vaccine? There’s money to be made, after all, and exploiting the bodies of little children for profit is just business as usual in a fascist nation dominated by corporate interests.

Pfizer sued by retailers over anticompetitive scheme

Adding to all this, Pfizer has now been sued by five U.S. retailers (pharmacies) who accuse the company of monopolistic market practices. According to the lawsuit, Pfizer conspired to prevent generic versions of its blockbuster cholesterol drug Lipitor from entering the market. This was done to protect billions in profits while making sure patients did not have access to more affordable cholesterol drugs. Pfizer sells nearly $10 billion worth of Lipitor each year.

According to the Reuters report on this lawsuit, Pfizer is being accused of

• Obtaining a fraudulent patent

• Engaging in sham litigation

• Entering a price-fixing agreement to delay cheaper generics

• Entering arrangements with pharmacy benefit managers to force retailers to buy more Lipitor (chemical name is atorvastatin calcium)

No arrests or prosecution of Big Pharma executives

One of the most astonishing realizations in all this is that given all the criminal fraud, bribery, misrepresentation, lying to the FDA, price fixing and other crimes that are going on in the pharmaceutical industry, you’d think somebody somewhere might be arrested and charged with a crime, right?

Nope.

To date, not a single pharmaceutical CEO, marketing employee or drug rep has been charged with anything related to all this fraud. In America, drug company employees are “above the law” just like top mafia bosses of a bygone era.

How insane is this, exactly? Consider this:

Imagine if YOU, an individual, went around town bribing doctors, falsifying data, selling a fraudulent product to the government, lying to regulators, engaging in anti-trade price-fixing and threatening your employees into silence. What would happen to you?

You’d probably wind up rotting in prison, the subject of an FBI investigation and a DoJ prosecution.

So why is it okay for a multi-billion-dollar corporation to carry out these same crimes and get away with it? Why are the CEOs of top drug companies given a free pass to commit felony crimes and endless fraud?

I’ll tell you why, and you’re not gonna like the answer: Because America has become a nation run by crooks for the benefit of crooks. It’s one big country club, and as comedian George Carlin used to say, “YOU ain’t in it!”

If Big Pharma would falsify data on vaccines, what else would the industry do?

I hope you’re getting the bigger picture in all this, friends. If these drug companies routinely bribe doctors, falsify data, defraud the government and commit felony crimes without remorse, what else would they be willing to do for profit?

Would they:

• Falsify efficacy data on other prescription drugs?

• Exploit children for deadly vaccine trials?

• Invent fictitious diseases to sell more drugs?

• Unleash bioweapons to cause a profitable pandemic?

• Conspire with the CDC to spread fear to promote vaccinations?

• Silence whistleblowers who try to go public with the truth?

• Give people cancer via stealth viruses in vaccines?

• Destroy the careers of medical scientists who question Big Pharma?

• Force a medical monopoly on the entire U.S. population via socialist health care legislation?

But of course they would. In fact, the industry is doing all those things right now. And if you don’t believe me, just remember that five years ago, no one believed me when I said drug companies were engaged in criminal conspiracies to defraud the nation — something that has now been proven over a nine-year investigation.

via Big Pharma criminality no longer a conspiracy theory: Bribery, fraud, price fixing now a matter of public record.

via Big Pharma criminality no longer a conspiracy theory: Bribery, fraud, price fixing now a matter of public record.

Can you Trust big business? A look at Pfizer Inc


Industry Area: Pfizer is a research-based global pharmaceutical company. The company discovers, develops, manufactures and markets medicines for humans and animals, as well as consumer products.

Overview

Market share/importance:

‘There were times not long ago that drug companies were merely the size of nations. Now, after a frenzied two-year period of pharmaceutical mega-mergers, they are behemoths, which outweigh entire continents. The combined worth of the world’s top five drug companies is twice the combined GNP of all sub-Saharan Africa and their influence on the rules of world trade is many times stronger because they can bring their wealth to bear directly on the levers of western power.’[1]

Pfizer is the largest and richest pharmaceutical enterprise in the world. Fortune® named Pfizer as the fifth-best ‘wealth-creator’ in America. The company is a global leader in human pharmaceuticals, and also has a large array of consumer health care, confectionery, and animal health care products. In 2000, its revenues equalled $29,6 billion (£20,14bn), eight of Pfizer’s pharmaceutical products attained sales of at least $1 billion (£680,4 million) each [2]. Pfizer’s main competitors are Merck, Glaxo SmithKline, Novartis, Brystol Myers Squibb and AstraZeneca.

In 2001, Pfizer has budgeted approximately $5 billion (£3,402 bn) for research and development -more than any other drug company in the world [3]. However, the company is likely to spend even more money on marketing. Extensive marketing practices (e.g. huge TV advertising campaigns) have turned some drugs, like Claritin and Viagra, into household names. According to the Financial Times (26 April 2001), ‘Pfizer has powered its way up the global ranking list to its unassailable position thanks mainly to its marketing prowess.’

History:

The company was incorporated as Charles Pfizer & Co in the US in 1942 but the original business dates back to a partnership founded in 1849. Until the turn of the century this partnership produced only citric acid but then began to expand into other chemicals and pharmaceutical products. A phase of rapid growth began with the production of penicillin in World War II (it was Pfizer penicillin that arrived with the Allied forces on the beaches of Normandy in 1944) and the development of the company’s most famous product, the antibiotic Terramycin in 1949. Based on this strength, Pfizer grew in the 40s and 50s through horizontal integration in the US as well as through internal development.

Under the methodical directive of John Powers, head of international operations and future president and chief executive officer, Pfizer’s foreign market expanded into 100 countries and accounted for $175 million (£199 million) in sales by 1965. It would be years before any competitor came close to commanding a similar share of the foreign market. Pfizer’s 1965 worldwide sales figures of $220 million (£149,7 million) indicated that the company might possibly be the largest pharmaceutical manufacturer in the US. By 1980 Pfizer was one of the two US companies among the top ten pharmaceutical companies in Europe, and the largest foreign health care and agricultural product manufacturer in Asia. Powers guided the company in a new direction with an emphasis on research and development.

By 1989, Pfizer operated in more than 140 countries. Pfizer entered the 90s facing controversy about heart valves produced by Shiley, a Pfizer subsidiary. In 1990, 38 fractures of implanted valves were reported (see also crime section). Pfizer became a household name in the late 90s with its development of the break-through male impotence drug Viagra, which became the world’s fastest-selling pharmaceutical product (until overtaken by another Pfizer brand).

It appears Viagra also had an effect on the company’s senior executives; in 1999 they began forcing their intentions on rival Warner-Lambert, finally harassing the smaller company into a shotgun marriage in the first ever-hostile take-over in the pharma sector. This take-over turned Pfizer into the largest and richest pharmaceutical enterprise in the world.

Pfizer has worked its way up the global ranking list by way of internal growth and development, acquisitions, the licensing of products from competitors (Pfizer generously borrowed research from its competitors and released variants of these drugs. While all companies participated in this process of ‘molecular manipulation’, whereby a slight variance is produced in a given molecule to develop greater potency and decreased side effects in a drug, Pfizer was particularly adept at developing these drugs and aggressively seizing a share of the market), research & development, and by way of comprehensive marketing efforts.

Pfizer’s successful marketing efforts impinged on other companies in the pharma sector. (Pfizer’s modern market campaigns broke tradition in the pharma industry. Pfizer’s Terramycin campaign turned the company –a relative newcomer to the industry—into the largest advertiser in the American Medical Association’s journal. Some companies did not appreciate Pfizer’s ‘hard sell’ tactics and attacked Pfizer. However, after Pfizer’s campaign proved to be highly effective, other companies took a similar lead) It is manifested in the “arms race” of escalating numbers of sales representatives, particularly in the US; the huge pre-launch marketing budgets when companies try to make as big a splash as possible; and aggressive TV advertising campaigns in which drugs are seemingly being treated and presented to the consumer audience as any other consumer product.

Pfizer recently announced a new mission: to become the world’s ‘most valued’ company. Pfizer CEO McKinnell declared that the new mission came about because the old mission set in the 1990s (to lead the pharmaceutical industry) had been achieved. He explains: ‘Becoming most values simply means that we emerge as the company recognised as the best by patients, customers, business partners, and the communities where we live and work. It’s a long term mission focused on making Pfizer’s success a winning proposition for everyone.’[4]

Environmental record

According to the EPA, Pfizer is among the top ten companies in America with the most numerous emissions sources.[88] A landfill and two wastewater lagoons in Ledyard, CT near the Pfizer plant in Groton, Connecticut, are a source of groundwater pollution in the area. According to the Connecticut Department of Environmental Protection (CT DEP), the Pfizer site is active under the CT DEP Site Remediation program.[89] In June 2002, a chemical explosion at the Groton plant injured seven people and caused the evacuation of over 100 homes in the surrounding area.[90]

Pfizer has inherited Wyeth’s liabilities in the American Cyanamid site in Bridgewater, New Jersey. This site is highly toxic and an EPA declared Superfund site. Pfizer has since attempted to remediate this land in order to clean and develop it for future profits and potential public uses. Members of the surrounding communities have stated that the EPA has been coerced into accepting a plan that is affordable for Pfizer but is not a complete/proper remediation plan for the site, detrimental to the interest of the community. The EPA has suggested a remediation plan that includes environmental caps and redeveloping a portion of it in the future. This redevelopment will occur on the site which is located within a flood plain, something the EPA failed to address in their feasibility study released in early 2012. The mayor of Bridgewater, the New Jersey Department of Environmental Protection, and other key community leaders also came out to endorse the plan without considering the amount of increased flooding that is going to take place if such a plan is implemented.[

Litigation

Pfizer is party to a number of suits stemming from its pharmaceutical products as well as practices of various companies it has acquired or merged with

eg Bjork–Shiley heart valve

Pfizer purchased Shiley in 1979 at the onset of its Convexo-Concave valve ordeal, involving the Bjork–Shiley heart valve. Approximately 500 people died when defective valves failed and, in 1994, the United States ruled against Pfizer for ~$200 million.[

Off-label promotional practices

Main article: Franklin v. Parke-Davis

Access to pharmaceutical industry documents has revealed marketing strategies used to promote Neurontin for off-label use.[51] In 1993, the U.S. Food and Drug Administration (FDA) approved gabapentin (Neurontin, Pfizer) only for treatment of seizures. Warner–Lambert, which merged with Pfizer in 2000, used activities not usually associated with sales promotion, including continuing medical education and research, sponsored articles about the drug for the medical literature, and alleged suppression of unfavorable study results, to promote gabapentin. Within 5 years the drug was being widely used for the off-label treatment of pain and psychiatric conditions. Warner–Lambert admitted to charges that it violated FDA regulations by promoting the drug for pain, psychiatric conditions, migraine, and other unapproved uses, and paid $430 million to resolve criminal and civil health care liability charges.[52][53] Today it is a mainstay drug for migraines, even though it was not approved for such use in 2004

Bextra settlement of off-label marketing investigation

In September 2009, the United States Department of Justice announced that Pfizer had agreed to pay $2.3 billion to settle civil and criminal allegations that it had illegally marketed four drugs: Bextra, Geodon, Zyvox, and Lyrica “with the intent to defraud or mislead” by promoting the drugs for non-approved uses[examples needed]; this marks Pfizer’s fourth such settlement in a decade.[9][10][46] Pharmacia & Upjohn Company, Inc., a Pfizer subsidiary, agreed to plead guilty to mis-branded promotion of Bextra, a felony violation of the Food, Drug and Cosmetic Act. The criminal fine accounts for $1.3 billion of the settlement, and was the largest criminal penalty imposed in American history until the BP plea agreement for the Deepwater Horizon oil spill

Nigeria

In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives traveled to Kano, Nigeria to administer an experimental antibiotic, trovafloxacin, to approximately 200 children. Local Kano officials report that more than 50 children died in the experiment, while many others developed mental and physical deformities.[65] In 2001, families of the children, as well as the governments of Kano and Nigeria, filed lawsuits regarding the treatment.[66] Representing the government is Babatunde Irukera. According to news reports, “[r]esearchers did not obtain signed consent forms, and medical personnel said Pfizer did not tell parents their children were getting the experimental drug.”[67] The lawsuits also accuse Pfizer of using the outbreak to perform unapproved human testing, as well as allegedly under-dosing a control group being treated with traditional antibiotics in order to skew the results of the trial in favor of Trovan. Pfizer denied these claims, and subsequently produced an approval letter for testing from the Nigerian Ethics Committee. The Nigerian government insisted that it was a fake and a panel of Nigerian medical experts agreed that the letter had been concocted and backdated by the company’s lead researcher in Kano. They went on to conclude that Pfizer never obtained authorization from the Nigerian government to give the unproven drug to children and infants.[68]

In 2007, Pfizer published a Statement of Defense letter.[69] The letter makes several claims, including that Pfizer donated 18 million in Nigerian Naira (NGN) (about $216,000 in 1996 US dollars (USD)),[70] that the drug’s oral form was presented as safer and easier to administer, that the administration of Trovan saved lives, and that no unusual side effects, unrelated to meningitis, were observed after 4 weeks.

A more likely reason for Pfizer’s insistence on the oral form is the result of testing trovafloxacin intravenously in 1995, which found that the drug precipitated in saline, making it ineffective in patients receiving IV fluids. This is inferred from an FDA Warning Letter[71] to ex-CEO William C. Steere, regarding Trovan’s compatibility with saline etc., which was omitted from Trovan’s labeling until January 1999, shortly after Pfizer received the letter.

In June 1999, the FDA released a public health statement warning against the use of Trovan except in life-or-death situations, due to high risk of liver failure. In some cases, liver damage occurred after only two days of treatment.[72]

In June 2010, the US Supreme Court rejected Pfizer’s appeal against a ruling allowing lawsuits by the Nigerian families to proceed.[73]

In December 2010, WikiLeaks released US diplomatic cables, which indicate that Pfizer had “used dirty tricks to avoid clinical trial payout”. The company had hired investigators to find evidence of corruption against the Nigerian attorney general to persuade him to drop legal action.[74] Washington Post reporter Joe Stephens, who helped break the story in 2000, called these actions “dangerously close to blackmail.”[67] In response, the company has released a press statement describing the allegations as “preposterous” and stating that they acted in good faith.[75]

Tomorrow : Can you Trust big business?  GlaxoSmithKline plc

 

via Pfizer Inc : Overview.

via Pfizer Inc : Overview.

Sweden: A Cautionary Tale About Vaccines


In 2009, the swine flu hit Europe in pandemic levels.

The countries rushed to acquire a vaccine called Pandemrix, made by GlaxoSmithKline in the UK.

The vaccine had been fast-tracked for use due to the human swine flu crisis.

One wealthy nation, Sweden, snapped up a large amount of the Pandemrix vaccine and launched a nationwide campaign, eventually vaccinating 59% of the population against the swine flu.

This may sound familiar — the vaccine was promoted by national health organizations, the main stream news, schools, workplaces and on television to encourage everyone to get the jab.

800 children across Europe diagnosed with incurable neurological disorder

A few months later a strange medical trend developed.

Medical professionals began seeing case after case of children suffering from narcolepsy.

And these children had one thing in common: they had been injected with the Pandemrix vaccine.

More than 800 children across Europe have been diagnosed with this incurable neurological disorder and the evidence is overwhelming in the implication of the vaccine.

The drug contained squalene which was used as an adjuvant.

Squalene is the most likely culprit in the vaccine. (Source)

The Tragic Story of Emelie

One young girl, Emelie Olsson, has had her life forever devastated as a result of narcolepsy, the onset of which occurred after receiving the swine flu vaccine in 2009.

The 14 year old girl has had her life devastated.

She cannot sleep at night.

When she does sleep, she is plagued with nightmares and hallucinations, sometimes waking more than 70 times in the night.

Sometimes when she wakens she is completely paralyzed and unable to breathe well or call out for help.

During the day, she can hardly keep her eyes open because of the lack of sleep.

If she laughs she has something called a cataplexy — when a strong emotion causes sudden muscle weakness that leaves her unable to stand.

When Emelie tries to have fun with friends, the happiness, literally, causes her to collapse to the ground.

She said in an interview:

”I can’t laugh or joke about with my friends anymore, because when I do I get cataplexies and collapse.

I can not laugh anymore and it makes me very, very sad.

It is the worst of all.”

Can you honestly imagine, as a parent, an adult or a human being, having to warn a child — “Stop that!  Don’t laugh!!!!”

But Emelie’s mother has to do just that.

In an interview, Marie Olsson expressed terrible guilt and regret.   (translated from Swedish)

“Yes, I feel guilty.

We are parents supposed to protect our children and instead I have asked Emelie take this vaccination, which has made her so sick.

If I had read on better and questioned more then maybe she had not been vaccinated themselves.

Before then, Emelie had been healthy.”

Emelie, age 14, must now take stimulants during the day, narcotic sleep aids at night and medications that stabilise her emotions so that she can feel neither sadness or joy.

She must take these medications for the rest of her life.

Emelie’s struggle is outlined in the documentary “After the Syringe.”

Lest the pro-vaccine crown think that Emelie’s story is merely anecdotal, there is enough evidence to support claims that GSK’s toxic concoction caused the 800 reported cases of narcolepsy to convince experts like Emmanuel Mignot, of Stanford University, who one of the world’s leading experts on narcolepsy.

”There’s no doubt in my mind whatsoever that Pandemrix increased the occurrence of narcolepsy onset in children in some countries — and probably in most countries.”

Europe’s regulatory board, the European Medicines Agency, has now directed that the vaccine should not be given to anyone under the age of 20.

One public health official in Sweden has gone on the record stating that things should have been different.

Goran Stiernstedt, the director for health and social care at the Swedish Association of Local Authorities and Regions, was at the helm of the vaccination campaign across Sweden.

He estimates the vaccine may have saved the lives of 30-60 people, but now over 200 recipients suffer from narcolepsy. (source)

“The big question is was it worth it?

And retrospectively I have to say it was not…

This is a medical tragedy…

Hundreds of young people have had their lives almost destroyed.”

Some experts say the risk is still worthwhile.

David Salisbury, the UK’s director of immunization, seems to think that the quality of life of 800 children is a small price to pay.

He told Reuters:

“In the event of a severe pandemic, the risk of death is far higher than the risk of narcolepsy.

If we spent longer developing and testing the vaccine on very large numbers of people and waited to see whether any of them developed narcolepsy, much of the population might be dead.”

Salisbury, of course, is neck-deep in his involvement with the very ethically questionable World Health Organization.

He has served as the Chairman of WGO Strategic Advisory Group of Experts (SAGE) on vaccines, and as a member of WHO’s Global Advisory Committee on Vaccine Safety.

He is the Co-chairman of the Influenza Pandemic Preparedness Group for the Global Health Security Action Group of G7 countries.

Indeed, his pro-vaccine interest in the “greater good” far outweighs his concern about the risks to children like Emelie.

No Responsibility Taken

No one seems willing to take responsibility for the lifelong damages suffered by these children.

Sweden gave GSK indemnity when they purchased the drug, which means that those affected by the vaccine cannot ask for damages from the manufacturer.

To receive compensation, the state is asking parents to

”…forever renounce the right to ask anyone to account in court for what has happened.

The condition has no counterpart in any other type of insurance, and only have the task of protecting drug manufacturers from lawsuits.”

Margareta Eriksson, President of Narcolepsy Association, responded:   (translated from Swedish: source)

We can never write such a thing.

We parents requiring instead that:

The state clearly take responsibility for our children’s future, and ensure that our children receive full compensation for economic losses without limiting insurance.

All the vaccine itself and then got narcolepsy should be entitled to compensation — without having to fight for it against the insurer.

The state ran a vaccination campaign that gave our children a life-long severe illness.

Now, the state must also take responsibility for the consequences.  (Source)

Still Pushing Vaccines

One health official in Norway has called the Pandermix tragedy a medical catastrophe.

“Narcolepsy following Pandemrix [vaccination] was completely unexpected and surprising, and a catastrophe.

Preben Aavitsland, who was responsible for monitoring contagious diseases at Norway’s Institute of Public Health in 2009 when the Swine Flu hit, cited studies in Finland, Sweden and here.

He told NRK these concluded that children given the Pandemrix vaccine had a 10 times-higher risk of developing narcolepsy than adults, calculations he states that Norwegian experts had not carried out. ” (Source)

Despite these statistics, there is still a push for the influenza vaccine in the Scandinavian countries.

“The Institute of Public Health declares the current flu vaccine is not the same as the Pandemrix vaccine and urges that those in risk groups such as those over the age of 65 or suffering from other health problems consider vaccination.” (Source)

What Can We Learn from This?

There are a few take-home lessons from this tale:

First of all, something vastly under-tested was brought to the market.

That vaccine was not merely made available, it was pushed, promoted and practically forced on people using a campaign of fear and guilt.

Children have been forever damaged by this vaccine.

No one wants to take financial responsibility for a life sentence of mental suffering, expensive daily medications and serious health issues.

Officials know these things are true but want you to continue to be vaccinated (and have your children vaccinated) anyway.

This story is a cautionary tale.

It tells us (and simply reaffirms for many of us) that we cannot accept anything that Big Pharma and their cohorts at the FDA and the CDC tell us.

If they lied to people in Europe can we really think they are telling us the truth in the United States and Canada?

We cannot accept what the media tells us at face value — who do you think sponsors the news programs?

Pay attention to the ads — you’ll see commercials for over the counter medications, SSRI antidepressants and other Big Pharma goodies interspersed throughout.

Whether the goal is to line their own pockets, to control the masses or to depopulate, this illustrates that our children are seen as nothing more than human laboratory animals.

These medications that are brought to market and all but forced on us are just a big science experiment.

The mind control and brainwashing by the mainstream culture is a psychological game, convincing people that it’s all for their own good.

You can turn on the TV right now and flip through a few channels and see the identical agenda at work in North America, where nearly every newscast mentions at least once during the 30 minute program, where, how or why you should rush out, roll up your sleeve, and get your flu shot.

What happened in Sweden is a direct example of what is going on, RIGHT NOW, across the western world, regarding the flu shot.

The tragedy that has afflicted these families could easily occur here.

If you can’t see the correlation between the two, your eyes and mind are willfully closed.

Don’t be fooled.

Don’t be brainwashed.

Don’t end up like Emelie and her parents.

via Vaccines Autism — Flu Swine Flu Children — Vitamin D3 — Robert Kennedy.

via Vaccines Autism — Flu Swine Flu Children — Vitamin D3 — Robert Kennedy.

Can you Trust big Business? Practicing the most stark acts of corporate inhumanity -Pharmaceutical Giants


Pharmaceutical Giants

‘There were times not long ago that drug companies were merely the size of nations. Now, after a frenzied two-year period of pharmaceutical mega-mergers, they are behemoths, which outweigh entire continents. The combined worth of the world’s top five drug companies is twice the combined GNP of all sub-Saharan Africa and their influence on the rules of world trade is many times stronger because they can bring their wealth to bear directly on the levers of western power.

The pharmaceutical industry is one of the most profitable industries in both the US and Great Britain. Gross Profit margins of some of the leading pharmaceutical companies in recent years has been around 70 to 80 percent [1].

The global drugs market is controlled by corporate behemoths such as Pfizer, Bristol-Myers Squibb, Bayer, Merck & Co, Pharmacia, Novartis, Johnson&Johnson, Abbott Laboratories, American Home Products, Eli Lilly, Schering-Plough, GlaxoSmithKline and Allergan. Their market domination enables them to dictate drug prices . In past years, pharmaceutical prices have risen faster than the rate of inflation. The fact that there is very little price elasticity (the elasticity of demand tells us how much the quantity demanded changes when the price changes) associated with price increases is a major factor contributing to the high profitability of the pharmaceutical industry. A patient will not change the demand for a product with a small change in price when there are no close or available substitutes. Actual manufacturing costs of medicines are relatively low [2].

The big pharmaceutical companies’ profits can be even higher due to limited competition in the pharmaceutical industry caused by strict patent laws [when a company owns a patent for a key drug, profits can mount up since the company faces no competition] and high barriers for small firms [new competitors] to enter the industry. In addition, through a recent and ongoing wave of mergers and acquisitions the big companies intensify the process of consolidation [limiting competition in the so-called free market even further]. Also, more frequently strategic alliances (less costly than mergers and acquisitions) are being formed with small biotech companies in order to reap the (new) economic benefits biotechnology offers. The drug giants cannot keep track of all new developments themselves, but want to keep their pipelines full

Tomorrow: Can you Trust big business? A look at Pfizer Inc

via Corporate Watch : Overview : Overview.

via Corporate Watch : Overview : Overview.

MovieBabble

The Casual Way to Discuss Movies

OLD HOLLYWOOD IN COLOR

...because it was never black & white

LEANNE COLE

Art and Practice

CURNBLOG

Movies, thoughts, thoughts about movies.

FilmBunker

Saving you from one cinematic disaster at a time.

From 1 Blogger 2 Another

Sharing Great Blog Posts

Wonders in the Dark

Cinema, music, opera, books, television, theater

Just Reviews

Just another WordPress.com site

Mark David Welsh

Watching the strangest movies - so you don't have to...

conradbrunstrom

Things I never thunk before.

News from the San Diego Becks

The life and times of Erik, Veronica and Thomas

The Silent Film Quarterly

The Only Magazine Dedicated To Silent Cinema

Leaden Circles

First a warning, musical; then the hour, irrevocable. The leaden circles dissolved in the air.

My Archives

because the internet is not forever

CineSocialUK

Up to the minute, fair, balanced, informed film reviews.

PUZZLED PAGAN PRESENTS

A Shrine to Pop Culture Obsessiveness. With Lots of Spoilers

Thrilling Days of Yesteryear

“Nostalgia isn’t what it used to be” – Peter DeVries

thedullwoodexperiment

Viewing movies in a different light

Twenty Four Frames

Notes on Film by John Greco

Suzanne's Mom's Blog

Arts, Nature, Family, Good Works, Luna & Stella Birthstone Jewelry

It Doesn't Have To Be Right...

... it just has to sound plausible

NJ Corporate Portrait Photographer Blog

The life of a corporate portrait photographer who likes to shoot just about anything.

arwenaragornstar

A French girl's musings...

Jordan and Eddie (The Movie Guys)

Australian movie blog - like Margaret and David, just a little younger

Octopus Films

A place for new perspectives on films, TV, media and entertainment.

scifist 2.0

A sci-fi movie history in reviews

The Reviewer's Corner

The Sometimes Serious Corner of the Internet for Anime, Manga, and Comic Reviews

First Impressions

Notes on Films and Culture

1,001 Movies Reviewed Before You Die

Where I Review One of the 1,001 Movies You Should Watch Before you Die Every Day

Movies Galore of Milwaukee

Movie Galore takes a look at Silent films on up to current in development projects and gives their own opinion on what really does happen in film!

The Catwing Has Landed

A Writer's Blog About Life and Random Things

mibih.wordpress.com/

Anime - Movies - Wrestling

Gabriel Diego Valdez

Movies and how they change you.

The Horror Incorporated Project

Lurking among the corpses are the body snatchers....plotting their next venture into the graveyard....the blood in your veins will run cold, your spine tingle, as you look into the terror of death in tonight's feature....come along with me into the chamber of horrors, for an excursion through.... Horror Incorporated!

Relatos desde mi ventana

Sentimientos, emociones y reflexiones

Teri again

Finding Me; A site about my life before and after a divorce

unveiled rhythms

Life In Verses

Gareth Roberts

Unorthodox Marketing & Strategy

leeg schrift

Taalarmen

100 Films in a Year

12 months. 100 films. Hopefully.

%d bloggers like this: